Antibody Drug Conjugates Market
The advancement of oncology treatment has increasingly focused on precision-driven therapies that enhance effectiveness while reducing adverse effects. Antibody drug conjugates (ADCs) have emerged as a transformative innovation by combining monoclonal antibodies with highly potent cytotoxic agents. Rising Demand for Advanced Biologic TherapiesThe growing emphasis on personalized medicine and targeted therapies is driving the development … Read more